Guided Therapeutics Secures $700,000 Order from Chinese Distributor for LuViva Systems

Reuters

06/10

Guided <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Secures $700,000 Order from Chinese Distributor for LuViva Systems

Guided Therapeutics Inc. has announced a significant new contract, receiving a $700,000 purchase order and initial payment from its new Chinese distributor, Hangzhou Dongye Medical Technology Company Ltd (HDMT). The order consists of 35 LuViva Advanced Cervical Scan systems, which will be assembled and tested by Guided Therapeutics' partner, Shandong Yaohua Medical Instrument Corporation. HDMT, based in Hangzhou City, is the exclusive provider of gynecology products for 42 hospitals in Zhejiang Province, where approximately two million cervical cancer screenings are conducted annually. Yang Dongye, CEO of HDMT, expressed the company's goal to eventually replace current screening tests with LuViva. Guided Therapeutics plans to begin shipments next month, marking a significant step in expanding LuViva's presence in the region.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guided Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250610216570) on June 10, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2542312439"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2542312439\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2542312439?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-10 21:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2542312439","market":"us","top_or_hot":-1,"title":"Guided Therapeutics Secures $700,000 Order from Chinese Distributor for LuViva Systems","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Guided <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Secures $700,000 Order from Chinese Distributor for LuViva Systems\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Guided Therapeutics Inc. has announced a significant new contract, receiving a $700,000 purchase order and initial payment from its new Chinese distributor, Hangzhou Dongye Medical Technology Company Ltd (HDMT). The order consists of 35 LuViva Advanced Cervical Scan systems, which will be assembled and tested by Guided Therapeutics' partner, Shandong Yaohua Medical Instrument Corporation. HDMT, based in Hangzhou City, is the exclusive provider of gynecology products for 42 hospitals in Zhejiang Province, where approximately two million cervical cancer screenings are conducted annually. Yang Dongye, CEO of HDMT, expressed the company's goal to eventually replace current screening tests with LuViva. Guided Therapeutics plans to begin shipments next month, marking a significant step in expanding LuViva's presence in the region.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guided Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250610216570) on June 10, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guided Therapeutics Secures $700,000 Order from Chinese Distributor for LuViva Systems</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuided Therapeutics Secures $700,000 Order from Chinese Distributor for LuViva Systems\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-06-10 21:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Guided <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Secures $700,000 Order from Chinese Distributor for LuViva Systems\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Guided Therapeutics Inc. has announced a significant new contract, receiving a $700,000 purchase order and initial payment from its new Chinese distributor, Hangzhou Dongye Medical Technology Company Ltd (HDMT). The order consists of 35 LuViva Advanced Cervical Scan systems, which will be assembled and tested by Guided Therapeutics' partner, Shandong Yaohua Medical Instrument Corporation. HDMT, based in Hangzhou City, is the exclusive provider of gynecology products for 42 hospitals in Zhejiang Province, where approximately two million cervical cancer screenings are conducted annually. Yang Dongye, CEO of HDMT, expressed the company's goal to eventually replace current screening tests with LuViva. Guided Therapeutics plans to begin shipments next month, marking a significant step in expanding LuViva's presence in the region.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guided Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250610216570) on June 10, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"醫療保健設備","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDLb9sjvD:1","article_id":"2542312439","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2542312439","pubTimestamp":1749560440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Guided Therapeutics Inc. has announced a significant new contract, receiving a $700,000 purchase order and initial payment from its new Chinese distributor, Hangzhou Dongye Medical Technology Company Ltd . The order consists of 35 LuViva Advanced Cervical Scan systems, which will be assembled and tested by Guided Therapeutics' partner, Shandong Yaohua Medical Instrument Corporation. HDMT, based in Hangzhou City, is the exclusive provider of gynecology products for 42 hospitals in Zhejiang Province, where approximately two million cervical cancer screenings are conducted annually. Yang Dongye, CEO of HDMT, expressed the company's goal to eventually replace current screening tests with LuViva. Guided Therapeutics plans to begin shipments next month, marking a significant step in expanding LuViva's presence in the region.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, t","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","GTHP":"Guided Therapeutics, Inc."},"translate_title":"Guided Therapeutics获得LuViva Systems中国经销商70万美元的订单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GTHP":0.9},"content_text":"Guided Therapeutics Secures $700,000 Order from Chinese Distributor for LuViva Systems\n    \n\n        Guided Therapeutics Inc. has announced a significant new contract, receiving a $700,000 purchase order and initial payment from its new Chinese distributor, Hangzhou Dongye Medical Technology Company Ltd (HDMT). The order consists of 35 LuViva Advanced Cervical Scan systems, which will be assembled and tested by Guided Therapeutics' partner, Shandong Yaohua Medical Instrument Corporation. HDMT, based in Hangzhou City, is the exclusive provider of gynecology products for 42 hospitals in Zhejiang Province, where approximately two million cervical cancer screenings are conducted annually. Yang Dongye, CEO of HDMT, expressed the company's goal to eventually replace current screening tests with LuViva. Guided Therapeutics plans to begin shipments next month, marking a significant step in expanding LuViva's presence in the region.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guided Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250610216570) on June 10, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}